Cell line · CVCL_5239
Papers21
1 to 20 of 21
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway. | Oncogenesis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FRA1 drives melanoma metastasis through an actionable transcriptional network. | Oncogene | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The IFNγ-CIITA-MHC II axis modulates melanoma cell susceptibility to NK-cell-mediated cytotoxicity. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| FRA1 drives melanoma metastasis through an actionable transcriptional network. | bioRxiv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| PHGDH Induction by MAPK Is Essential for Melanoma Formation and Creates an Actionable Metabolic Vulnerability. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy. | Cell | 2024 | Its Methods give the RRID and name the line | PubMed | |
| p300 KAT Regulates SOX10 Stability and Function in Human Melanoma. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. | NAR Cancer | 2024 | Its Methods give the RRID and name the line | PubMed | |
| PTEN Lipid Phosphatase Activity Suppresses Melanoma Formation by Opposing an AKT/mTOR/FRA1 Signaling Axis. | Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Gain of Chromosome 1q Perturbs a Competitive Endogenous RNA Network to Promote Melanoma Metastasis. | Cancer Res | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Learning from Embryogenesis-A Comparative Expression Analysis in Melanoblast Differentiation and Tumorigenesis Reveals miRNAs Driving Melanoma Development. | J Clin Med | 2021 | Its Methods give the RRID and name the line | PubMed | |
| 1205Lu is human melanoma depending on the source. | 2016 | Cellosaurus cites it | DOI | ||
| Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines. | Pigment Cell Melanoma Res | 2015 | Cellosaurus cites it | PubMed | |
| 1205Lu human metastatic melanoma cells, not human! | 2013 | Cellosaurus cites it | DOI | ||
| Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas. | Mol Cancer Ther | 2008 | Cellosaurus cites it | PubMed | |
| Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression. | Cancer Res | 2008 | Cellosaurus cites it | PubMed | |
| Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. | Pigment Cell Res | 2006 | Cellosaurus cites it | PubMed | |
| High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity. | Cancer Immunol Immunother | 2005 | Cellosaurus cites it | PubMed | |
| Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. | Am J Pathol | 1993 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_5239/papers